COVID-19 Pathophysiology & the Rationale for why Molecular Hydrogen is being clinically investigated

This video discusses COVID-19 pathophysiology and the rationale for why H2 is being clinically investigated. Molecular hydrogen (H2 gas) has antioxidant and anti-inflammatory effects (1), which make it potentially useful for COVID-19. Several clinical studies in China are investigating H2 therapy in COVID-19 patients (2,3). The preliminary results appear to be quite positive (4,5), which has prompted Dr. Zhong Nanshan, the epidemiologist who discovered the SARS Coronavirus in 2003, to recommend H2 therapy for COVID-19 (6). The latest version of the official guide for the diagnosis and treatment of COVID-19 by the Chinese National Health Commission includes hydrogen inhalation as a recommendation (7,8,9). However, more research is needed to confirm these positive preliminary results. (see also ref 10,11 in Chinese). Again, there is still no clinically published evidence that H2 will truly benefit COVID-19 and this information is solely for educational purposes and does not constitutes clinical evidence and is